{
  "ptid_time": "116_S_4732_2012-05-31",
  "img_path": "/data/qiuhui/data/adni/images/116_S_4732/2012-05-31/t1.nii.gz",
  "img_finding": "Image findings: hippocampal volume measures 6,802 mm³, 10.0% below the reference mean. With a Z-score of -0.98 (16.4th percentile), this represents normal volume ; whole brain volume measures 1,169,290 mm³, 8.3% above the reference mean. With a Z-score of 1.08 (86.0th percentile), this represents mild enlargement. ",
  "text_data": "Age is 77.2 years. Gender is Male. Education: 20 years. Handedness: Right. Race: White. Medical history: Psychiatric; Head, Eyes, Ears, Nose and Throat; Cardiovascular; Dermatologic-Connective Tissue; Endocrine-Metabolic; Gastrointestinal; Renal-Genitourinary; Allergies or Drug Sensitivities; Smoking; Malignancy; Major Surgical Procedures. MMSE: 21.0. MoCA: 19.0. Logical Memory: 3.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 0.97 SUVR (normal ); Amyloid beta: 402.40 pg/mL (moderate reduced); Total tau: 361.20 pg/mL (moderate elevated); Phosphorylated tau: 38.42 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "**Reasoning:** The hippocampal volume is within normal limits, but the MMSE and MoCA scores indicate cognitive impairment. Biomarkers (Aβ reduction, elevated T-tau and P-tau) suggest Alzheimer's pathology despite normal AV45 (amyloid PET). The cognitive deficits and biomarker profile align with dementia.  \n\n**Diagnosis:** **Dementia (likely Alzheimer’s disease)**  \n**Confidence:** **Medium** (Cognitive scores strongly suggest impairment, but amyloid PET is normal, which is atypical for AD—could be tau-predominant or mixed pathology.)",
  "timestamp": "2025-07-26T12:13:50.157565"
}